Two of three patients with multiple chemical sensitivity had less symptoms and secondary hyperalgesia after transcranially applied pulsed electromagnetic fields.
← Research streamIn an open case study of three MCS patients receiving transcranially applied PEMF, two patients showed considerable improvement on measures of MCS-related symptoms/functional impairments, depressive symptoms, and capsaicin-induced secondary punctate hyperalge…
Study snapshot
Abstract
Background Multiple chemical sensitivity (MCS) is a chronic, disabling condition characterized by recurrent multisystem symptoms triggered by common airborne chemicals. Evidence points towards abnormal sensory processing in the central nervous system (CNS) as a likely pathophysiological mechanism. No effective treatment has yet been reported, but clinical observations suggest that as pulsed electromagnetic fields (PEMF) is a treatment for some CNS disorders (depression and chronic pain), it may also be a treatment modality for MCS. Methods In an open case study, the effects of PEMF were assessed in three MCS patients. All cases received 30 min daily treatment 5 days a week for 8 consecutive weeks. Symptoms and functional impairments related to MCS, depressive symptoms, and capsaicin-induced secondary punctate hyperalgesia were assessed at baseline and weekly until an 18-week follow-up. Results Two of the three cases showed considerable improvement on all measures of symptoms and functional impairments related to MCS in response to PEMF therapy. One case showed no improvement and during the treatment period was unexpectedly diagnosed with depression. Conclusion Our findings indicate potential benefits of PEMF therapy in MCS. Implication The therapeutic effect of PEMF in MCS needs to be investigated by a randomized placebo-controlled trial.
AI evidence extraction
Structured fields below were generated from the paper’s abstract and metadata to make the evidence easier to inspect. Automated extraction may be incomplete or incorrect; verify important details against the original paper.
Main findings
In an open case study of three MCS patients receiving transcranially applied PEMF, two patients showed considerable improvement on measures of MCS-related symptoms/functional impairments, depressive symptoms, and capsaicin-induced secondary punctate hyperalgesia. One patient showed no improvement and was unexpectedly diagnosed with depression during the treatment period.
Outcomes measured
- MCS-related symptoms
- MCS-related functional impairments
- Depressive symptoms
- Capsaicin-induced secondary punctate hyperalgesia
Limitations
- Open case study design (no randomization/placebo control)
- Very small sample size (n=3)
View raw extracted JSON
{
"study_type": "case_report",
"exposure": {
"band": null,
"source": "transcranially applied pulsed electromagnetic fields (PEMF) therapy",
"frequency_mhz": null,
"sar_wkg": null,
"duration": "30 min daily, 5 days/week for 8 consecutive weeks; follow-up to 18 weeks"
},
"population": "Patients with multiple chemical sensitivity (MCS)",
"sample_size": 3,
"outcomes": [
"MCS-related symptoms",
"MCS-related functional impairments",
"Depressive symptoms",
"Capsaicin-induced secondary punctate hyperalgesia"
],
"main_findings": "In an open case study of three MCS patients receiving transcranially applied PEMF, two patients showed considerable improvement on measures of MCS-related symptoms/functional impairments, depressive symptoms, and capsaicin-induced secondary punctate hyperalgesia. One patient showed no improvement and was unexpectedly diagnosed with depression during the treatment period.",
"effect_direction": "mixed",
"limitations": [
"Open case study design (no randomization/placebo control)",
"Very small sample size (n=3)"
],
"evidence_strength": "very_low",
"confidence": 0.78,
"peer_reviewed_likely": "yes",
"keywords": [
"multiple chemical sensitivity",
"MCS",
"pulsed electromagnetic fields",
"PEMF",
"transcranial",
"central nervous system",
"depression",
"chronic pain",
"secondary hyperalgesia",
"capsaicin"
],
"suggested_hubs": []
}AI-extracted fields are generated from the abstract and metadata and may be incomplete or incorrect. This material is for informational purposes and is not medical advice.
Identifiers and source
DOI: 10.1016/j.sjpain.2013.11.008
PubMed: 29913674
Related papers
- Randomised, placebo-controlled trial of transcranial pulsed EMF in patients with multiple chemical sensitivity 2016
- Molecular biomarkers in Electrohypersensitivity and Multiple Chemical Sensitivity: How They Can 2024
- Prevalence and correlation of multiple chemical sensitivity and electromagnetic hypersensitivity with age, sex, and depression in the Japanese population: a retrospective study 2023
- Why the psychogenic or psychosomatic theories for electrohypersensitivity causality should be abandoned, but not the hypothesis of a nocebo-associated symptom formation caused by EMF conditioning in some patients 2022
- Why electrohypersensitivity and related symptoms are caused by non-ionizing man-made electromagnetic fields: An overview and medical assessment 2022
- Technical Assessment of Ultrasonic Cerebral Tomosphygmography and New Scientific Evaluation of Its Clinical Interest for the Diagnosis of Electrohypersensitivity and Multiple Chemical Sensitivity 2020